HOME > TOP STORIES
TOP STORIES
-
ACADEMIA Japanese Society of Medical Oncology to Update I/O Guidelines in October
July 18, 2018
-
BUSINESS Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo
July 17, 2018
-
TRENDS As Biosimilars Show Mixed Performances, Lantus Follow-On Is on a Roll
July 13, 2018
-
BUSINESS Otsuka Ventures into Antibody Space with Visterra Buyout
July 12, 2018
-
REGULATORY MHLW Selects 9 Priority Prefectures for Generic Promotion Project, but Leaves Tokyo Out
July 12, 2018
-
REGULATORY MHLW Official Expounds on “Authorized Biosimilar” Pricing, 50% Generic Rule Applies for “Biosame” Products
July 11, 2018
-
REGULATORY Tokyo Govt to Launch Support Program for Drug Discovery Startups to Solve Obstacles to Fundraising, IP Strategy
July 10, 2018
-
BUSINESS New Takeda Global Headquarters Designed for LGBT Inclusion
July 9, 2018
-
BUSINESS No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
July 6, 2018
-
BUSINESS Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
July 5, 2018
-
REGULATORY Several Brand-Name Drug Makers Intend to Withdraw “G1” LLPs
July 4, 2018
-
TRENDS Japan Drug Makers Downsizing Parent Companies; Takeda Sheds Over 1,000 People in Divestitures, R&D Rejig
July 3, 2018
-
REGULATORY MHLW Approves Entyvio, Imfinzi, Lynparza Breast Cancer Use, and More
July 3, 2018
-
BUSINESS Takeda Celebrates Grand Opening for New Global Headquarters
July 3, 2018
-
BUSINESS With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
July 2, 2018
-
BUSINESS Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
June 29, 2018
-
BUSINESS Takeda Shareholders Strike Down Dissident Group’s Proposal
June 28, 2018
-
BUSINESS Keytruda’s MSI-H Cancer Indication to Be Reviewed Under Conditional Early Approval System
June 28, 2018
-
BUSINESS Chugai Chairman Prods Drug Makers to Innovate, Chides Calls for Relaxed Pricing
June 27, 2018
-
ACADEMIA Licensee Selection Draws Near for AMED-Backed Cancer Mouth Sores Treatment
June 26, 2018
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
